(1)
Novel Sustained-Release Nateglinide Microspheres: In Vitro Evaluation for Improved Antidiabetic Therapy. JOC 2025, 24 (6s), 232-242. https://doi.org/10.64149/J.Carcinog.24.6s.232-242.